Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study
ConclusionMaintenance apatinib was safe and achieved encouraging PFS and OS in extensive-stage SCLC.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Hypertension | Lung Cancer | Oral Cancer | Proteinuria | Small Cell Lung Cancer | Study | Thrombocytopenia | Toxicology